Abeona licenses UNC-Chapel Hill's AIM AAV gene therapy for Batten disease
- Gene Therapy, Cell Therapy
- Large Molecule
- Controlled Release
- Drug Delivery
- R+D and Marketing-Licensing
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.